Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV003009045 | SCV003296592 | pathogenic | Tuberous sclerosis 2 | 2022-08-16 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with TSC2-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.4903_4917del, results in the deletion of 5 amino acid(s) of the TSC2 protein (p.Cys1635_Arg1639del), but otherwise preserves the integrity of the reading frame. This variant disrupts a region of the TSC2 protein in which other variant(s) (p.Lys1638del) have been determined to be pathogenic (PMID: 17304050, 20165957, 21520333, 22867869). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |